ISRCTN ISRCTN84269958
DOI https://doi.org/10.1186/ISRCTN84269958
Protocol serial number R40 MC03622
Sponsor University of Washington (USA)
Funder Maternal and Child Health Bureau - Health Resources and Services Administration (MCHB - HRSA) (USA)
Submission date
07/02/2008
Registration date
26/02/2008
Last edited
31/08/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Peter Milgrom
Scientific

Dental Public Health Sciences
1959 NE Pacific Street
Rm B-509
Box 357475
Seattle
98195
United States of America

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific titleXylitol for acute otitis media and early childhood caries
Study objectivesXylitol syrup reduces the incidence of dental caries and acute otitis media
Ethics approval(s)University of Washington Institutional Review Board, initial approval granted on 19 July 2005 (ref: HSD# 04-4039-B 01). The approval has been renewed annually on 17 August 2006 (ref: HSD# 04-4039-B 02) and 12 August 2007 (ref:HSD# 04-4039-B 03).
Health condition(s) or problem(s) studiedDental caries and acute otitis media
InterventionThree group design:
1. Xylitol syrup 8 g/day divided into 2 doses + 1 dose of sorbitol = 3 doses/day
2. Xylitol syrup 8 g/day divided into 3 doses + 0 dose of sorbitol = 3 doses/day
3. Xylitol syrup 2.66 g/day in a single dose (positive control) + 2 doses of sorbitol = 3 doses/day

Duration of interventions: 12 months
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Xylitol
Primary outcome measure(s)1. Dental caries, assessed at baseline (at randomization), mid study (5-6 months), and 12 months (end of study period)
2. Acute otitis media (incidence rate). Children were assessed as symptoms suggestive of acute otitis media arose throughout the follow-up period (12 months)
Key secondary outcome measure(s)No secondary outcome measures
Completion date15/01/2008

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit6 Months
Upper age limit15 Months
SexAll
Target sample size at registration102
Key inclusion criteriaChildren aged 6-15 months of age living in Laura or Delap district of Majuro Atoll, the Marshall Islands
Key exclusion criteriaChildren with known gastrointestinal problems
Date of first enrolment01/04/2006
Date of final enrolment15/01/2008

Locations

Countries of recruitment

  • Marshall Islands
  • United States of America

Study participating centre

Dental Public Health Sciences
Seattle
98195
United States of America

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2009 Yes No